ArticleDegenerative neurological and neuromuscular disease2026
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program.
Antonio Carotenuto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.